Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

Progress in Neurobiology

Volumn 70, Issue 1, 2003, Pages 1-32

  Turner, Paul R ^a   O'Connor, Kate ^a   Tate, Warren P ^a   Abraham, Wickliffe C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTISENSE OLIGONUCLEOTIDE; APOLIPOPROTEIN E; APROTININ; BETA SECRETASE; CHOLINERGIC RECEPTOR; CORTICOSTERONE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC GMP; CYSTEINE; DIACYLGLYCEROL; DISINTEGRIN; G PROTEIN COUPLED RECEPTOR; GAMMA SECRETASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; KININOGEN; LOW DENSITY LIPOPROTEIN; METABOTROPIC RECEPTOR; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NICOTINIC RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; UNINDEXED DRUG;

ALZHEIMER DISEASE; BINDING SITE; CELL ACTIVITY; CELL ADHESION; CELL STRUCTURE; CELLULAR DISTRIBUTION; COGNITIVE DEFECT; CYTOLOGY; ENZYME LOCALIZATION; HUMAN; LEARNING; LONG TERM POTENTIATION; MEMORY; MEMORY DISORDER; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SYNAPTIC TRANSMISSION; TRANSGENIC ANIMAL;

EID: 0042634362     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(03)00089-3     Document Type: Review

References (290)

1. Acquati F., Accarino M., Nucci C., Fumagalli P., Jovine L., Ottolenghi S., Taramelli R. The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett. 468:2000;59-64.
2. Albert R., Jeong H., Barabási A. Error and attack tolerance of complex networks. Nature. 406:2000;378-382.
3. Allsop D., Landon M., Kidd M. The isolation and amino acid composition of senile plaque core protein. Brain Res. 259:1983;348-352.
4. Almkvist O., Basun H., Wagner S.L., Rowe B.A., Wahlund L.O., Lannfelt L. Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation. Arch. Neurol. 54:1997;641-644.
5. Alzheimer, A., 1907. A characteristic disease of the cerebral cortex. In: Bick, K., Amaducci, L., Pepeu, G. (Eds.), The Early Story of Alzheimer's Disease. Liviana Press, Padova, Italy, pp. 1-3.
6. Anders A., Gilbert S., Garten W., Postina R., Fahrenholz F. Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J. 15:2001;1837-1839.
7. Anderson J.J., Holtz G., Baskin P.P., Wang R., Mazzarelli L., Wagner S.L., Menzaghi F. Reduced cerebralspinal fluid levels of α-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits. Neuroscience. 93:1999;1409-1420.
8. Ando K., Iijima K.I., Elliott J.I., Kirino Y., Suzuki T. Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid. J. Biol. Chem. 276:2001;40353-40361.
9. Annaert W.G., Esselens C., Baert V., Boeve C., Snellings G., Cupers P., Craessaerts K., De Strooper B. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron. 32:2001;579-589.
10. Arendt T. Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease. Int. J. Dev. Neurosci. 19:2001;231-241.
11. Armogida M., Petit A., Vincent B., Scarzello S., da Costa C.A., Checler F. Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts. Nat. Cell Biol. 3:2001;1030-1033.
12. Artola A., Singer W. Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation. Trends Neurosci. 16:1993;480-487.
13. Barger S.W., Basile A.S. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J. Neurochem. 76:2001;846-854.
14. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388:1997a;878-881.
15. Barger S.W., Mattson M.P. The secreted form of the Alzheimer's beta-amyloid precursor protein stimulates a membrane bound guanylate cyclase. Biochem. J. 311:1995;45-47.
16. Barger S.W., Mattson M.P. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol. Brain Res. 40:1996;116-126.
17. Barger S.W., Mattson M.P., Donald W. Isoform-specific modulation by apolipoprotein E of the activities of secreted beta-amyloid precursor protein. J. Neurochem. 69:1997;60-67.
18. Beher D., Hesse L., Masters C.L., Multhaup G. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I. J. Biol. Chem. 271:1996;1613-1620.
19. Bennett B.D., Babu-Khan S., Loeloff R., Louis J.C., Curran E., Citron M., Vassar R. Expression analysis of BACE2 in brain and peripheral tissues. J. Biol. Chem. 275:2000;20647-20651.
20. Berger-Sweeny J., McPhie D.L., Arters J.A., Greenan J., Oster-Granite M.L., Neve R.L. Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. Mol. Brain Res. 66:1999;150-162.
21. Bienenstock E.L., Cooper L.N., Munro P.W. Theory for the development of neuron selectivity: orientation specificity and binocular interaction in visual cortex. J. Neurosci. 2:1982;32-48.
22. Birmingham K., Frantz S. Set back to Alzheimer vaccine studies. Nat. Med. 8:2002;199-200.
23. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 385:1997;729-733.
24. Boland K., Behrens M., Choi D., Manias K., Perimutter D.H. The serpin-enzyme complex receptor recognizes soluble, non-toxic amyloid-β peptide but not aggregated, cytotoxic amyloid-β peptide. J. Biol. Chem. 271:1996;18032-18044.
25. Bolshakov V.Y., Carboni L., Cobb M.H., Siegelbaum S.A., Belardetti F. Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses. Nat. Neurosci. 3:2000;1107-1112.
26. Borg J.P., Ooi J., Levy E., Margolis B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell Biol. 16:1996;6229-6241.
27. Breen K.C., Bruce M., Anderton B.H. Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J. Neurosci. Res. 28:1991;90-100.
28. Brou C., Logeat F., Gupta N., Bessia C., LeBail O., Doedens J.R., Cumano A., Roux P., Black R.A., Israel A. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell Biol. 5:2000;207-216.
29. o heterotrimeric protein within a cell compartment specialized in signal transduction. J. Neurosci. 19:1999;1717-1727.
30. Bruni P., Minopoli G., Brancaccio T., Napolitano M., Faraonio R., Zambrano N., Hansen U., Russo T. Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression. J. Biol. Chem. 277:2002;35481-35488.
31. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., Black R.A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273:1998a;27765-27767.
32. Buxbaum J.D., Thinakaran G., Koliatsos V., O'Callahan J.O., Slunt H.H., Price D.O., Sisodia S.S. Alzheimer amyloid precursor protein in the rat hippocampus: transport and processing through the perforant path. J. Neurosci. 18:1998b;9629-9637.
33. Cai H., Wang Y., McCarthy D., Wen H., Borchelt D.R., Price D.L., Wong P.C. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4:2001;233-234.
34. Campbell A. β-Amyloid: friend or foe? Med. Hypoth. 56:2001;388-391.
35. Cao X., Sudhof T.C. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science. 293:2001;115-120.
36. Capell A., Grunberg J., Pesold B., Diehlmann A., Citron M., Nixon R., Beyreuther K., Selkoe D.J., Haass C. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J. Biol. Chem. 273:1998;3205-3211.
37. Capell A., Steiner H., Willem M., Kaiser H., Meyer C., Walter J., Lammich S., Multhaup G., Haass C. Maturation and pro-peptide cleavage of beta-secretase. J. Biol. Chem. 275:2000;30849-30854.
38. Caporaso G.L., Takei K., Gandy S.E., Matteoli M., Mundigl O., Greengard P., De Camilli P. Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer beta/A4 amyloid precursor protein. J. Neurosci. 14:1994;3122-3138.
39. Carette B., Poulain P., Delacourte A. Electrophysiological effects of 25-35 amyloid-β-protein on guinea-pig lateral septal neurons. Neurosci. Lett. 151:1993;111-114.
40. o mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4062-4066.
41. Cedazo-Minguez A., Cowburn R.F. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J. Cell. Mol. Med. 5:2001;254-266.
42. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V.P., Hyman B.T., Younkin S.G., Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2:1999;271-276.
43. Chen M., Yankner B.A. An antibody to beta amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types. Neurosci. Lett. 125:1991;223-226.
44. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., Morris R.G. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 408:2000a;975-978.
45. Chen Y., McPhie D.L., Hirschberg J., Neve R.L. The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J. Biol. Chem. 275:2000b;8929-8935.
46. Chen Q.S., Kagan B.L., Hirakura Y., Xie C.W. Impairment of hippocampal LTP by Alzheimer amyloid β-peptides. J. Neurosci. Res. 60:2000c;65-72.
47. Chen Q.S., Wei W.Z., Shimahara T., Xie C.W. Alzheimer amyloid-beta peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 77:2002;354-371.
48. Chishti M.A., Yang D.-S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., St. George-Hyslop P., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276:2001;21562-21570.
49. Choi S.H., Park C.H., Koo J.W., Seo J., Kim H., Sung-Jin J., Lee J., Kim S.S., Suh Y. Memory impairment and cholinergic dysfunction by centrally administered Aβ and carboxyl-terminal fragment of Alzheimer's APP in mice. FASEB J. 15:2001;1816-1818.
50. Chow N., Korenberg J.R., Chen X.N., Neve R.L. APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J. Biol. Chem. 271:1996;11339-11346.
51. Chrobak J.J., Buzsaki G. Operational dynamics in the hippocampal-entorhinal axis. Neurosci. Biobehav. Rev. 22:1998;303-310.
52. Colciaghi F., Borroni B., Pastorino L., Marcello E., Zimmermann M., Cattabeni F., Padovani A., Di Luca M. α-Secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med. 8:2002;67-74.
53. Conlon R.A., Reaume A.G., Rossant J. Notch1 is required for the coordinate segmentation of somites. Development. 121:1995;1533-1545.
54. Coussens C.M., Kerr D.S., Abraham W.C. Glucocorticoid receptor activation lowers the threshold for homosynaptic long-term depression in the hippocampus through activation of voltage-dependent calcium channels. J. Neurophysiol. 78:1997;1-9.
55. Cowburn R.F., Wiehager B., Trief E., Li-Li M., Sundström E. Effects of β-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor. Neurochem. Res. 22:1997;1437-1442.
56. Cruts M., Backhovens H., Wang S.Y., Van Gassen G., Theuns J., De Jonghe C.D., Wehnert A., De Voecht J., De Winter G., Cras P.et al. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum. Mol. Genet. 4:1995;2363-2371.
57. Cullen W.K., Wu J., Anwyl R., Rowan M.J. β-Amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. NeuroReport. 8:1996;87-92.
58. Cullen W.K., Suh Y., Anwyl R., Rowan M.J. Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments. Neuroreport. 8:1997;3213-3217.
59. Cupers P., Bentahir M., Craessaerts K., Orlans I., Vanderstichele H., Saftig P., De Strooper B., Annaert W. The discrepancy between presenilin subcellular localisation and γ-secretase processing of amyloid precursor protein. J. Cell Biol. 154:2001;731-740.
60. Das P., Murphy M.P., Younkin L.H., Golde T.E. Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol. Aging. 22:2001;721-727.
61. Das A., Smalheiser N.R., Markaryan A., Kaplan A. Evidence for binding of the ectodomain of amyloid precursor protein 695 and activated high molecular weight kininogen. Biochim. Biophys. Acta. 1571:2002;225-238.
62. Davis S., Vanhoutte P., Pages C., Caboche J., Laroche S. The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation in the dentate gyrus in vivo. J. Neurosci. 20:2000;4563-4572.
63. Dawson G.R., Seabrook G.R., Zheng H., Smith D.W., Graham S., O'Dowd G., Bowery B.J., Boyce S., Trumbauer M.E., Chen H.Y., Van der Ploeg L.H.T., Sirinathsingji J.S. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience. 90:1999;1-13.
64. De Strooper B., Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113:2000;1857-1870.
65. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 391:1998;387-390.
66. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., Schroeter E.H., Schrijvers V., Wolfe M.S., Ray W.J., Goate A., Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 398:1999;518-522.
67. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., Sweatt J.D. β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal a7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21:2001;4125-4133.
68. Doyle E., Bruce M.T., Breen K.C., Smith D.C., Anderton B., Regan C.M. Intraventricular infusions of antibodies to amyloid-β-protein precursor impair the acquisition of a passive avoidance response in the rat. Neurosci. Lett. 115:1990;97-102.
69. Dutar P., Potier B., Lamour Y. Short-term effects of beta-amyloid protein on CA1 hippocampal neurons in young and aged rats: a study of calcium-dependent events. Neurodegeneration. 3:1994;119-128.
70. Efthimiopoulos S., Punj S., Manolopoulos V., Pangalos M., Wang G.P., Refolo L.M., Robakis N.K. Intracellular cyclic AMP inhibits constitutive and phorbol ester-stimulated secretory cleavage of amyloid precursor protein. J. Neurochem. 67:1996;872-875.
71. Ekinci F.J., Malik K.U., Shea T.B. Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to β-amyloid. J. Biol. Chem. 274:1999;30322-30327.
72. Esler W.P., Wolfe M.S. A portrait of Alzheimer secretases - new features and familiar faces. Science. 293:2001;1149-1454.
73. Esler W.P., Kimberly W.T., Ostaszewski B.L., Ye W., Diehl T.S., Selkoe D.J., Wolfe M.S. Activity-dependent isolation of the presenilin-gamma-secretase complex reveals nicastrin and a gamma substrate. Proc. Natl. Acad. Sci. U.S.A. 99:2002;2720-2725.
74. Farber S.A., Nitsch R.M., Schulz J.G., Wurtman R.J. Regulated secretion of beta-amyloid precursor protein in rat brain. J. Neurosci. 15:1995;7442-7451.
75. Farzan M., Schnitzler C.E., Vasilieva N., Leung D., Choe H. BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc. Natl. Acad. Sci. U.S.A. 97:2000;9712-9717.
76. Fazeli M.S., Breen K.C., Errington M.L., Bliss T.V.P. Increase in extracellular NCAM and amyloid precursor protein following induction of long-term potentiation in the dentate gyrus of anaesthetized rats. Neurosci. Lett. 169:1994;77-80.
77. Feng R., Rampon C., Tang Y.-P., Shrom D., Jin J., Kyin M., Sopher B., Martin G.M., Kim S.-H., Langdon R.B., Sisodia S.S., Tsien J.Z. Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron. 32:2001;911-926.
78. Fischer P., Lassmann H., Jellinger K., Simanyi M., Bancher C., Travniczek-Marterer A., Gatterer G., Danielczyk W. Alzheimer dementia. A clinical long-term study with quantitative neuropathology. Wien Med. Wochenschr. 141:1991;455-462.
79. Fitzjohn S.M., Morton R.A., Kuenzi F., Rosahl T.W., Shearman M., Lewis H., Smith D., Reynolds D.S., Davies C.H., Collingridge G.L., Seabrook G.R. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J. Neurosci. 21:2001;4691-4698.
80. Flood J.F., Morley J.E., Roberts E. Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3363-3366.
81. Flood J.F., Morley J.E., Roberts E. An amyloid β-protein fragment, Aβ[21-28], equipotently impairs post-training memory processing when injected into different limbic system structures. Brain Res. 663:1994a;271-276.
82. Flood J.F., Roberts E., Sherman M.A., Kaplan B.E., Morley J.E. Topography of a binding site for small amnestic peptides deduced from structure-activity studies: relation to amnestic effect of amyloid β protein. Proc. Natl. Acad. Sci. U.S.A. 91:1994b;380-384.
83. Forloni G. Neurotoxicity of beta-amyloid and prion peptides. Curr. Opin. Neurol. 9:1996;492-500.
84. Forloni G., Tagliavini F., Bugiani O., Salmona M. Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides. Prog. Neurobiol. 49:1996;287-315.
85. Freir D.B., Holscher C., Herron C.E. Blockade of LTP by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85:2001;708-713.
86. Fukumoto H., Cheung B.S., Hyman B.T., Irizarry M.C. β-Secretase protein and activity are increased in the neocortex in Alzheimer's disease. Arch. Neurol. 59:2002;1381-1389.
87. Furukawa, K., 1998. Signaling by β-amyloid precursor protein. In: Mattson, M.P. (Ed.), Neuroprotective Signal Transduction. Human Press, Totowa, New Jersey, pp. 197-220.
88. Furukawa K., Mattson M.P. Secreted amyloid precursor protein α selectively supresses N-methyl-D-aspartate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience. 83:1998;429-438.
89. Furukawa K., Abe Y., Akaike N. Amyloid β protein-induced irreversible current in rat cortical neurones. NeuroReport. 5:1994;2016-2018.
90. + channels and suppression of neuronal activity by secreted β-amyloid-precursor protein. Nature. 379:1996a;74-78.
91. Furukawa K., Sopher B.L., Rydel R., Begley J.G., Pham D.G., Martin G.M., Fox M., Mattson M.P. Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67:1996b;1882-1896.
92. Garver W.S., Krishnan K., Gallagos J.R., Michikawa M., Francis G.A., Heidenreich R.A. Niemann-Pick C1 protein regulates cholesterol transport to the trans-Golgi network and plasma membrane caveolae. J. Lipid Res. 43:2002;579-589.
93. Giacchino J., Criado J.R., Games D., Henriksen S. In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice. Brain Res. 876:2000;185-190.
94. Giambarella U., Yamatsuji T., Okamoto T., Matsui T., Ikezu T., Murayama Y., Levine M.A., Katz A., Gautam N., Nishimoto I. G protein βγ complex-mediated apoptosis by familial Alzheimer's disease mutant of APP. EMBO J. 16:1997;4897-4907.
95. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L.et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
96. Goodman Y., Mattson M.P. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128:1994;1-12.
97. Gray C.W., Patel A.J. Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes. Mol. Brain Res. 19:1993;251-256.
98. Haass C., Koo E.H., Mellon A., Hung A.Y., Selkoe D.J. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 357:1992a;500-502.
99. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfry C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., Selkoe D.J. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992b;322-327.
100. Haniu M., Denis P., Young Y., Mendiaz E.A., Fuller J., Hui J.O., Bennett B.D., Kahn S., Ross S., Burgess T., Katta V., Rogers G., Vassar R., Citron M. Characterization of Alzheimer's beta-secretase protein BACE. A pepsin family member with unusual properties. J. Biol. Chem. 275:2000;21099-21106.
101. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12:1991;383-388.
102. Harper J.D., Lansbury P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66:1997;385-407.
103. Hartmann D., de Strooper B., Serneels L., Craessaerts K., Herreman A., Annaert W., Umans L., Lubke T., Lena Illert A., von Figura K., Saftig P. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 11:2002;2615-2624.
104. Hawkins R.D., Son H., Arancio O. Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. Prog. Brain Res. 118:1998;155-172.
105. Hayashi H., Mizuno T., Michikawa M., Haass C., Yanagisawa K. Amyloid precursor protein in unique cholesterol-rich microdomains different from caveolae-like domains. Biochim. Biophys. Acta. 1483:2000;81-90.
106. Heber S., Herms J., Gajic V., Hainfellner J., Aguzzi A., Rulicke T., von Kretzschmar H., von Koch C., Sisodia S., Tremml P., Lipp H.P., Wolfer D.P., Muller U. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20:2000;7951-7963.
107. Helmuth L. New therapies. New Alzheimer's treatments that may ease the mind. Science. 297:2002;1260-1262.
108. Herz J., Strickland D.K. LRP: a multifunctional scavenger and signalling receptor. J. Clin. Invest. 108:2001;779-784.
109. Hescheler J., Rosenthal W., Trautwein W., Schultz G. The GTP-binding protein, Go, regulates neuronal calcium channels. Nature. 325:1987;445-447.
110. Hoffman J., Pietrzik C.U., Kummer M.P., Twiesselmann C., Bauer C., Herzog V. Binding and selective detection of the secretory N-terminal domain of the Alzheimer amyloid precursor protein on cell surfaces. J. Histochem. Cytochem. 47:1999;373-382.
111. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Gen. 29:1999;177-185.
112. Howlett D.R., Jennings K.H., Lee D.C., Clark M.S., Brown F., Wetzel R., Wood S.J., Camilleri P., Roberts G.W. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration. 4:1995;23-32.
113. Hsia A.Y., Masliah E., McConlogue L., Yu G.-Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3228-3233.
114. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
115. Huber G., Martin J.R., Löffler J., Moreau J.-L. Involvement of amyloid precrusor protein in memory formation in the rat: an indirect antibody approach. Brain Res. 603:1993;348-352.
116. Huber G., Bailly Y., Martin J.R., Mariani J., Brugg B. Synaptic β-amyloid precursor proteins increase with learning capacity in rats. Neuroscience. 80:1997;313-320.
117. Huse J.T., Pijak D.S., Leslie G.J., Lee V.M., Doms R.W. Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. J. Biol. Chem. 275:2000;33729-33737.
118. Hutton M., Busfield F., Wragg M., Crook R., Perez-Tur J., Clark R.F., Prihar G., Talbot C., Phillips H., Wright K., Baker M., Lendon C., Duff K., Martinez A., Houlden H., Nichols A., Karran E., Roberts G., Roques P., Rossor M., Venter J.C., Adams M.D., Cline R.T., Phillips C.A., Goate A.et al. Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. NeuroReport. 7:1996;801-805.
119. Ishida A., Furukawa K., Keller J.N., Mattson M.P. Secreted form of β-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. NeuroReport. 8:1997;2133-2137.
120. Itoh A., Akaike T., Sokabe M., Nitta A., Iida R., Olariu A., Yamada K., Nabeshima T. Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats. Eur. J. Pharmacol. 382:1999;167-175.
121. Iversen L.L., Mortishire R.J., Pollack S.J., Shearman M.S. The toxicity in vitro of β-amyloid protein. Biochem. J. 311:1995;1-16.
122. Janus C., Pearson J., McLaurin J., Matthews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T.J., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St George-Hyslop P., Westaway D. Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
123. Jarrett J.T., Berger E.P., Lansbury P.T. Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697.
124. Jhamandas J.H., Cho C., Jassar B., Harris K., MacTavish D., Easaw J. Cellular mechanisms for amyloid β-protein activation of rat cholinergic basal forebrain neurons. J. Neurophysiol. 86:2001;1312-1320.
125. Ji D., Lape R., Dani J.A. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron. 31:2001;131-141.
126. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., Goldstein S.B. Kinesin-mediated axonal transport of a membrane compartment containing γ-secretase and presenilin-1 requires APP. Nature. 414:2001;643-648.
127. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
128. Kar S., Seto D., Gaudreau P., Quirion R. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J. Neurosci. 16:1996;1034-1040.
129. Kawas C., Resnick S.M., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology. 48:1997;1517-1521.
130. Kibbey M.C., Jucker M., Weeks B.S., Neve R.L., Van Nostrand W.E., Kleinman H.K. β-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10150-10153.
131. Kim J.-H., Anwyl R., Suh Y.-H., Djamgoz M.B.A., Rowan M.J. Use-dependent effects of amyloidogenic fragments of β-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci. 21:2001;1327-1333.
132. Kimberly W.T., Zheng J.B., Guenette S.Y., Selkoe D.J. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 276:2001;40288-40292.
133. Kimura A., Horikoshi M. Tip60 acetylates six lysines of a specific class in core histones in vitro. Genes Cells. 3:1998;789-800.
134. Kinoshita A., Whelan C.M., Smith C.J., Mikhailenko I., Rebeck G.W., Strickland D.K., Hyman B.T. Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65. J. Neurosci. 21:2001;8354-8361.
135. Kinoshita A., Whelan C.M., Berezovska O., Hyman B.T. Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J. Neurochem. 82:2002a;839-847.
136. Kinoshita A., Whelan C.M., Berezovska O., Hyman B.T. The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J. Biol. Chem. 277:2002b;28530-28536.
137. Kirazov L., Loffler T., Schliebs R., Bigl V. Glutamate-stimulated secretion of amyloid precursor protein from cortical rat brain slices. Neurochem. Int. 30:1997;557-563.
138. Kirazov E., Kirazov L., Bigl V., Schliebs R. Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo. Int. J. Dev. Neurosci. 19:2001;287-296.
139. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 331:1988;530-532.
140. Klein W.L., Krafft G., Finch C.E. Targeting small amyloid-beta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24:2001;219-224.
141. Knauer M.F., Orlando R.A., Glabe C.G. Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalised via the low density lipoprotein receptor-related protein (LRP). Brain Res. 740:1996;6-14.
142. Koike H., Tomioka S., Sorimachi H., Saido T.C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K., Ishiura S. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343:1999;371-375.
143. Kotlinek L.A., Bacskai B., Westerman M., Kawarabayashi T., Younkin L., Hyman B.T., Younkin S., Ashe K.H. Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J. Neurosci. 22:2002;6331-6335.
144. Koudinov A.R., Koudinova N.V. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J. 15:2001;1858-1860.
145. Kounnas M.Z., Moir R.D., Rebeck G.W., Bush A.I., Argraves W.S., Tanzi
146. Kovacs D.M., Fausett H.J., Page K.J., Kim T.W., Moir R.D., Merriam D.E., Hollister R.D., Hallmark O.G., Mancini R., Felsenstein K.M., Hyman B.T., Tanzi R.E., Wasco W. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2:1996;224-229.
147. Krugers H.J., Mulder M., Korf J., Havekes L., de Kloet E.R., Joels M. Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice. NeuroReport. 8:1997;2505-2510.
148. Kumar V.B., Farr S.A., Flood J.F., Kamlesh V., Franko M., Banks W.A., Morley J.E. Site-directed antisense oligonucleotides decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 21:2000;1769-1775.
149. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6448-6453.
150. Lammich S., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3922-3927.
151. Lannfelt L., Basun H., Wahlund L.-O., Rowe B.A., Wagner S.L. Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat. Med. 1:1995;829-832.
152. Larson J., Lynch G., Games D., Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840:1999;23-35.
153. Leem J.Y., Vijayan S., Han P., Cai D., Machura M., Lopes K.O., Veselits M.L., Xu H., Thinakaran G. Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J. Biol. Chem. 277:2002;19236-19240.
154. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
155. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293:2001;1487-1491.
156. Li H.L., Roch J.M., Sundsmo M., Otero D., Sisodia S., Saitoh T. Defective neurite extension is caused by a mutation in the amyloid beta/A4 (A beta) precursor found in familial Alzheimer's disease. J. Neurobiol. 32:1997;469-480.
157. Li Y., Liu L., Kang J., Sheng J.G., Barger S.W., Mrak R.E., Griffin W.S. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20:2000;149-155.
158. Lim L.C., Fang L., Swendeman S.L., Sheffery M. Characterization of the molecularly cloned murine alpha-globin transcription factor CP2. J. Biol. Chem. 268:1993;18008-18017.
159. Lopez-Perez E., Zhang Y., Frank S.J., Creemers J., Seidah N., Checler F. Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. J. Neurochem. 76:2001;1532-1539.
160. Lue L.-F., Kuo Y.-M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., Rogers J. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155:1999;853-862.
161. Luo Y., Bolon B., Kahn S., Bennett B.D., Babu-Khan S., Denis P., Fan W., Kha H., Zhang J., Gong Y., Martin L., Louis J.C., Yan Q., Richards W.G., Citron M., Vassar R. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neurosci. 4:2001;231-232.
162. Lynch C., Mobley W. Comprehensive theory of Alzheimer's disease. Ann. N.Y. Acad. Sci. 924:2000;104-111.
163. Malin D.H., Crothers M.K., Lake J.R., Goyarzu P., Plotner R.E., Garcia S.A., Spell S.H., Tomsic B.J. Hippocampal injections of amyloid β-peptide 1-40 impair subsequent one-trial/day reward learning. Neurobiol. Learn. Mem. 76:2001;125-137.
164. Matsumoto A., Itoh K., Matsumoto R. A novel carboxypeptidase B that processes native beta-amyloid precursor protein is present in human hippocampus. Eur. J. Neurosci. 12:2000;227-238.
165. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1997;1081-1132.
166. Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron. 10:1993;243-254.
167. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 294:2001;1354-1357.
168. McKee A.C., Kowall N.W., Schumacher J.S., Beal M.F. The neurotoxicity of amyloid beta protein in aged primates. Amyloid. 5:1998;1-9.
169. McLaughlin M., Breen K.C. Protein kinase C activation potentiates the rapid secretion of amyloid precursor protein from rat cortical synaptosomes. J. Neurochem. 72:1999;273-281.
170. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Bayreuther K., Bush A.I., Masters C.L. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46:1999;860-866.
171. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron. 24:1999;521-529.
172. Mesulam M.M. A plasticity-based theory of the pathogenesis of Alzheimer's disease. Ann. N.Y. Acad. Sci. 924:2000;42-52.
173. Meziane H., Dodart J.-C., Mathis C., Little S., Clemens J., Paul S.M., Ungerer A. Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12683-12688.
174. Mileusnic R., Lancashire C.L., Johnston A.N., Rose S.P.R. APP is required during an early phase of memory formation. Eur. J. Neurosci. 12:2000;4487-4495.
175. Mills J., Reiner P.B. Mitogen-activated protein kinase is involved in N-methyl-D-aspartate receptor regulation of amyloid precursor protein cleavage. Neuroscience. 94:1999;1333-1338.
176. Mok S.S., Sberna G., Heffernan D., Cappai R., Galatis D., Clarris H.J., Sawyer W.H., Beyreuther K., Masters C.L., Small D.H. Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's disease. FEBS Lett. 415:1997;303-307.
177. Morgan T.E., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., O'Connor K., Hatcher J., Hope C., Gordon M., Arendash G.W. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
178. o protein as signal transducer in the pertussis toxin-sensitive phosphatidylinositol pathway. Nature. 343:1990;79-82.
179. Morishima-Kawashima M., Ihara Y. Alzheimer's disease: β-amyloid protein and tau. J. Neurosci. Res. 70:2002;392-401.
180. Morley J.E., Kumar V.B., Bernado A.E., Farr S.A., Uezu K., Tumosa N., Flood J.F. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides. 21:2000;1761-1767.
181. Morley J.E., Farr S.A., Flood J.F. Antibody to amyloid β protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol. Learn. Mem. 78:2002;125-138.
182. Moss M.L., Jin S.L., Milla M.E., Bickett D.M., Burkhart W., Carter H.L., Chen W.J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schoenen F., Seaton T., Su J.L., Becherer J.D.et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 385:1997;733-736.
183. Moya K.L., Benowitz L.I., Schneider G.E., Allinquant B. The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev. Biol. 161:1994;597-603.
184. Mucke L., Masliah E., Johnson W.B., Ruppe M.D., Alford M., Rockenstein E.M., Forss-Petter S., Pietropaolo M., Mallory M., Abraham C.R. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res. 666:1994;151-167.
185. Mucke L., Abraham C.R., Masliah E. Neurotrophic and neuroprotective effects of hAPP in transgenic mice. Ann. N.Y. Acad. Sci. 777:1996;82-88.
186. Nag S., Tang F. The effect of age on the response of the rat brains to continuous β-amyloid infusion. Brain Res. 889:2001;303-307.
187. Nalbantoglu J., Tirado-Santiago G., Lahsaini A., Poirier J., Goncalves O., Verge G., Momoli F., Weiner S.A., Massicotte G., Jullen J.-P., Shapiro M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature. 387:1997;500-505.
188. Neve R.L., Finch E.A., Bird E.D., Benowitz L.I. Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc. Natl. Acad. Sci. U.S.A. 85:1988;3638-3642.
189. Neve R.L., Robakis N.K. Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci. 21:1998;15-19.
190. Ngezahayo A., Schachner M., Artola A. Synaptic activity modulates the induction of bidirectional synaptic changes in adult mouse hippocampus. J. Neurosci. 20:2000;2451-2458.
191. Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Okamoto T., Murayama Y., Ogata E. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature. 362:1993;75-79.
192. Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 258:1992;304-307.
193. Nitsch R.M., Farber S.A., Growdon J.H., Wurtman R.J. Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5191-5193.
194. Nitsch R.M., Deng A., Wurtman R.J., Growdon J.H. Metabotropic glutamate receptor subtype mGluR1α stimulates the secretion of the amyloid β-protein precursor ectodomain. J. Neurochem. 69:1997;704-712.
195. Nunan J., Small D.H. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483:2000;6-10.
196. Ohm T.G., Hamker U., Cedazo-Minguez A., Roeckl W., Scharnagl H., Maerz W., Cowburn R., Mueller W., Meske V. Apolipoprotein E and beta A4-amyloid: signals and effects. Biochem. Soc. Symp. 67:1999;121-129.
197. Oka J.-I., Suzuki E., Kondo Y. Endogenous GLP-1 is involved in β-amyloid protein-induced memory impairment and hippocampal neuronal death in rats. Brain Res. 878:2000;194-198.
198. Okamoto T., Takeda S., Murayama Y., Ogata E., Nishimoto I. Ligand-dependent G protein coupling function of amyloid transmembrane precursor. J. Biol. Chem. 270:1995;4205-4208.
199. Okamoto T., Takeda S., Giambarella U., Matsuura Y., Katada T., Nishimoto I. Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease. EMBO J. 15:1996;3769-3777.
200. Okuno H., Tokuyama W., Li Y.X., Hashimoto T., Miyashita Y. Quantitative evaluation of neurotrophin and trk mRNA expression in visual and limbic areas along the occipito-temporo-hippocampal pathway in adult macaque monkeys. J. Comp. Neurol. 408:1999;378-398.
201. Pakaski M., Rakonczay Z., Kasa P. Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal APP processing and protein kinase C levels in vitro. Neurochem. Int. 38:2001;219-226.
202. Parent A., Linden D.J., Sisodia S.S., Borchelt D.R. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 6:1999;56-62.
203. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalise aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron. 17:1996;553-565.
204. Parvathy S., Hussain I., Karran E.H., Turner A.J., Hooper N.M. Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry. 37:1998;1680-1685.
205. Parvathy S., Hussain I., Karran E.H., Turner A.J., Hooper N.M. Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells. Biochemistry. 38:1999;9728-9734.
206. Perez R.G., Zheng H., Van der Ploeg L.H.T., Koo E.H. The β-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 17:1997;9407-9414.
207. 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 21:2001;1-5.
208. Phinney A.L., Calhoun M.E., Wolfer D.P., Lipp H.P., Zheng H., Jucker M. No hippocampal neuron or synaptic bouton loss in learning-impaired aged β-amyloid precursor protein-null mice. Neuroscience. 90:1999;1207-1216.
209. Podlisny M.B., Ostaszewski B.L., Squazzo S.L., Koo E.H., Rydell R.E., Teplow D.B., Selkoe D.J. Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270:1995;9564-9570.
210. Ponting C.P., Hutton M., Nyborg A., Baker M., Jansen K., Golde T.E. Identification of a novel family of presenilin homologues. Hum. Mol. Genet. 11:2002;1037-1044.
211. Raymond C.R., Ireland D.R., Abraham W.C. NMDA receptor regulation by amyloid-β does not account for its inhibition of LTP in rat hippocampus. Brain Res. 968:2003;263-272.
212. Roberds S.L., Anderson J., Basi G., Bienkowski M.J., Branstetter D.G., Chen K.S., Freedman S.B., Frigon N.L., Games D., Hu K., Johnson-Wood K., Kappenman K.E., Kawabe T.T., Kola I., Kuehn R., Lee M., Liu W., Motter R., Nichols N.F., Power M., Robertson D.W., Schenk D., Schoor M., Shopp G.M., Shuck M.E., Sinha S., Svensson K.A., Tatsuno G., Tintrup H., Wijsman J., Wright S., McConlogue L. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10:2001;1317-1324.
213. Roch J.-M., Masliah E., Roch-Levecq A.-C., Sundsmo M.P., Otero D.A.C., Veinburgs I., Saitoh T. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7450-7454.
214. Roghani M., Becherer J.D., Moss M.L., Atherton R.E., Erdjument-Bromage H., Arribas J., Blackburn R.K., Weskamp G., Tempst P., Blobel C.P. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J. Biol. Chem. 274:1999;3531-3540.
215. Rohan de Silva H.A., Jen A., Wickenden C., Jen L.S., Wilkinson S.L., Patel A.J. Cell-specific expression of beta-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes. Mol. Brain Res. 47:1997;147-156.
216. Rossner S., Beck M., Stahl T., Mendla K., Schliebs R., Bigl V. Constitutive over activation of protein kinase C in guinea pig brain increases α-secretory APP processing without decreasing β-amyloid generation. Eur. J. Neurosci. 12:2000;3191-3200.
217. 3H ]acetylcholine release from mouse cerebral cortical synaptosomes J. Neurochem. 43:1984;1593-1598.
218. Russo T., Faraonio R., Minopoli G., De Candia P., De Renzis S., Zambrano N. Fe65 and the protein network centered around the cytosolic domain of the β-amyloid precursor protein. FEBS Lett. 434:1998;1-7.
219. Sabo S.L., Ikin A.F., Buxbaum J.D., Greengard P. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153:2001;1403-1414.
220. Saleshando G., O'Connor J.J. SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus. Neurosci. Lett. 288:2000;119-122.
221. Santiago-Garcia J., Mas-Oliva J., Innerarity T.L., Pitas R.E. Secreted forms of the amyloid-beta precursor protein are ligands for the class A scavenger receptor. J. Biol. Chem. 276:2001;30655-30661.
222. Saura C.A., Tomita T., Davenport F., Harris C.L., Iwatsubo T., Thinakaran G. Evidence that intra-molecular associations between presenilin domains are obligatory for endoproteolytic processing. J. Biol. Chem. 274:1999;13818-13823.
223. Scheinfeld M.H., Roncarati R., Vito P., Lopez P.A., Abdallah M., D'Adamio L. Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP). J. Biol. Chem. 277:2002;3767-3775.
224. Schlondorff J., Becherer J.D., Blobel C.P. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem. J. 347:2000;131-138.
225. Schmechel D.E., Goldgaber D., Burkhart D.S., Gilbert J.R., Gajdusek D.C., Roses A.D. Cellular localization of messenger RNA encoding amyloid-beta-protein in normal tissue and in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2:1988;96-111.
226. Schroeter E.H., Kisslinger J.A., Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 393:1998;382-386.
227. Schubert W., Prior R., Weidemann A., Dircksen H., Multhaup G., Masters C.L., Beyreuther K. Localization of Alzheimer beta A4 amyloid precursor protein at central and peripheral synaptic sites. Brain Res. 563:1991;184-194.
228. Seabrook G.R., Smith D.W., Bowery B.J., Easter A., Reynolds T., Fitzjohn S.M., Morton R.A., Zheng H., Dawson G.R., Sirinathsinghji D.J.S., Davies C.H., Collingridge G.L., Hill R.G. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology. 38:1999;349-359.
229. Seidah N.G., Chrétien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848:1999;45-62.
230. Selkoe D.J. Normal and abnormal biology of the beta-amyloid precursor protein. Ann. Rev. Neurosci. 17:1994;489-517.
231. Selkoe D.J., Podlisny M.B., Joachim C.L., Vickers E.A., Lee G., Fritz L.C., Oltersdorf T. Beta-amyloid precursor protein of Alzheimer disease occurs as 110-135-kilodalton membrane-associated proteins in neural and non-neural tissues. Proc. Natl. Acad. Sci. U.S.A. 85:1988;7341-7345.
232. Sennvik K., Fastbom J., Blomberg M., Wahlund L.-O., Winblad B., Benedikz E. Levels of α- and β-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci. Lett. 278:2000;169-172.
233. Sherrington R., Froelich S., Sorbi S., Campion D., Chi H., Rogaeva E.A., Levesque G., Rogaev E.I., Lin C., Liang Y., Ikeda M., Mar L., Brice A., Agid Y., Percy M.E., Clerget-Darpoux F., Piacentini S., Marcon G., Nacmias B., Amaducci L., Frebourg T., Lannfelt L., Rommens J.M., St George-Hyslop P.H. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum. Mol. Genet. 5:1996;985-988.
234. Shigematsu K., McGeer P.L., McGeer E.G. Localization of amyloid precursor protein in selective postsynaptic densities of rat cortical neurons. Brain Res. 592:1992;353-357.
235. Shirra M.K., Zhu Q., Huang H.C., Pallas D., Hansen U. One exon of the human LSF gene includes conserved regions involved in novel DNA-binding and dimerization motifs. Mol. Cell Biol. 14:1994;5076-5087.
236. Sisodia S.S. Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6075-6079.
237. Sisodia S.S., Koo E.H., Hoffman P.N., Perry G., Price D.L. Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J. Neurosci. 13:1993;3136-3142.
238. Sisodia S.S., Annaert W., Kim S.H., De Strooper B. Gamma-secretase: never more enigmatic. Trends Neurosci. 24:2001;S2-S6.
239. Slunt H.H., Thinakaran G., Von Koch C., Lo A.C., Tanzi R.E., Sisodia S.S. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). J. Biol. Chem. 269:1994;2637-2644.
240. Small D.H., Mok S.S., Bornstein J.C. Alzheimer's disease and Aβ toxicity: from top to bottom. Nat. Rev. Neurosci. 2:2001;595-598.
241. Snyder S.W., Ladror U.S., Wade W.S., Wang G.T., Barrett L.W., Matayoshi E.D., Huffaker H.J., Krafft G.A., Holzman T.F. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67:1994;1216-1228.
242. Stéphan A., Laroche S., Davis S. Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticty and causes memory deficits. J. Neurosci. 21:2001;5703-5714.
243. Storey E., Beyreuther K., Masters C.L. Alzheimer's disease amyloid precursor protein on the surface of cortical neurons in primary culture co-localizes with adhesion patch components. Brain Res. 735:1996;217-231.
244. Storey E., Katz M., Brickman Y., Beyreuther K., Masters C.L. Amyloid precursor protein of Alzheimer's disease: evidence for a stable, full-length, trans-membrane pool in primary neuronal cultures. Eur. J. Neurosci. 11:1999;1779-1788.
245. Strittmatter W.J. Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms. Biochem. Soc. Symp. 67:1999;101-109.
246. 25-35. J. Neurophysiol. 87:2001;2442-2449.
247. Suzuki T., Oishi M., Marshak D.R., Czernik A.J., Nairn A.C., Greengard P. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J. 13:1994;1114-1122.
248. Takano M., Sakanaka F., Okamoto H. Tissue-specific expression of rat kininogen mRNAs. Biol. Pharm. Bull. 23:2000;1239-1242.
249. Tanaka S., Shiojiri S., Takahashi Y., Kitaguchi N., Ito H., Kameyama M., Kimura J., Ueda K. Tissue-specific expression of three types of beta-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer's disease brain. Biochem. Biophys. Res. Commun. 165:1989;1406-1414.
250. Tarr P.E., Roncarati R., Pelicci G., Pelicci P.G., D'Adamio L. Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J. Biol. Chem. 277:2002;16798-16804.
251. Teather L.A., Magnusson J.E., Chow C.M., Wurtman R.J. Environmental conditions influence hippocampus-dependent behaviours and brain levels of amyloid precursor protein in rats. Eur. J. Neurosci. 16:2002;2405-2415.
252. Thiels E., Kanterewicz B.I., Norman E.D., Trzaskos J.M., Klann E. Long-term depression in the adult hippocampus in vivo involves activation of extracellular signal-regulated kinase and phosphorylation of Elk-1. J. Neurosci. 22:2002;2054-2062.
253. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A.I., Gandy S.E., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.
254. Tomimoto H., Akiguchi I., Wakita H., Nakamura S., Kimura J. Ultrastructural localization of amyloid protein precursor in the normal and postischemic gerbil brain. Brain Res. 672:1995;187-195.
255. Tyler S.J., Dawbarn D., Wilcock G.K., Allen S.J. α- and β-secretase: profound changes in Alzheimer's disease. Biochem. Biophys. Commun. 299:2002;373-376.
256. 2+ channels: a possible involvement of free radicals. J. Neurochem. 68:1997;265-271.
257. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286:1999;735-741.
258. Vitolo O.V., Sant'Angelo A., Costanzo V., Battaglia F., Arancio O., Shelanski M. Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. U.S.A. 99:2002;13217-13221.
259. von Koch C.S., Zheng H., Chen H., Trumbauer M., Thinakaran G., van der Ploeg L.H., Price D.L., Sisodia S.S. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging. 18:1997;661-669.
260. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., Teplow D.B. Amyloid β-protein fibrillogenesis. J. Biol. Chem. 274:1999;25945-25952.
261. Walsh D.M., Tseng B.P., Rydel R.E., Podlisny M.B., Selkoe D.J. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry. 39:2000;10831-10839.
262. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002a;535-539.
263. Walsh D.M., Klyubin I., Fadeeva J.V., Rowan M.J., Selkoe D.J. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30:2002b;552-557.
264. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity. J. Biol. Chem. 275:2000a;5626-5632.
265. Wang H.Y., Lee D.H., Davis C.B., Shank R.P. Amyloid peptide Abeta (1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J. Neurochem. 75:2000b;1155-1161.
266. Wang H.-W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., Trommer B.L. Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924:2002;133-140.
267. Weidemann A., Paliga K., Durrwang U., Czech C., Evin G., Masters C.L., Beyreuther K. Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and beta-amyloid precursor protein. Nat. Med. 3:1997;328-332.
268. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotlinek L., Kawarabayashi T., Younkin L.H., Carlson G.A., Younkin S.G., Ashe K.H. The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 33:2002;2858-2867.
269. Whitmarsh A.J., Kuan C.Y., Kennedy N.J., Kelkar N., Haydar T.F., Mordes J.P., Appel M., Rossini A.A., Jones S.N., Flavell R.A., Rakic P., Davis R.J. Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev. 15:2001;2421-2432.
270. Wilcock G.K., Esiri M.M. Plaques, tangles and dementia. A quantitative study. J. Neurol. Sci. 56:1982;343-356.
271. Wilson C.A., Doms R.W., Zheng H., Lee V.M. Presenilins are not required for A beta 42 production in the early secretory pathway. Nat. Neurosci. 5:2002;849-855.
272. Wolfe M.S., De Los Angeles J., Miller D.D., Xia W., Selkoe D.J. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease. Biochemistry. 38:1999a;11223-11230.
273. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T., Selkoe D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 398:1999b;513-517.
274. Wu J., Anwyl R., Rowan M.J. β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. NeuroReport. 6:1995;2409-2413.
275. Xia W., Zhang J., Perez R., Koo E.H., Selkoe D.J. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94:1997;8208-8213.
276. Yamada T., Kobayashi T. The mutation in amyloid precursor protein inhibits both alpha- and beta-secretion. Neurosci. Lett. 191:1995;103-106.
277. Yamatsuji T., Matsui T., Okamoto T., Komatsuzaki K., Takeda S., Fukumoto H., Iwatsubo T., Suzuki N., Asami-Odaka A., Ireland S., Kinane T.B., Giambarella U., Nishimoto I. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science. 272:1996;1349-1352.
278. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashier J.R., Stratman N.C., Mathews W.R., Buhl A.E., Carter D.B., Tomasselli A.G., Parodi L.A., Heinrikson R.L., Gurney M.E. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 402:1999;533-537.
279. Ye L., Qiao J.-T. Suppressive action produced by β-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: it's offset by (-)huperzine A. Neurosci. Lett. 275:1999;187-190.
280. Yen S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
281. Younkin S.G. Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37:1995;287-288.
282. Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A., Song Y.Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L., Yu H., Yang D.S., Holmes E., Milman P., Liang Y., Zhang D.M., Xu D.H., Sato C., Rogaev E., Smith M., Janus C., Zhang Y., Aebersold R., Farrer L.S., Sorbi S., Bruni A., Fraser P., St George-Hyslop P. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature. 407:2000;48-54.
283. Yu H., Saura C.A., Choi S., Sun L.D., Yang A.J., Handler M., Kawarabbayashi T., Younkin L.B.F., Wilson M.A., Younkin S., Kandel E.R., Kirkwood A., Shen J. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron. 31:2001;713-726.
284. Zamani M.R., Allen Y.S. Nicotine and its interaction with β-amyloid protein: a short review. Biol. Psychiat. 49:2001;221-232.
285. Zambrano N., Minopoli G., De Candia P., Russo T. The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J. Biol. Chem. 273:1998;20128-20133.
286. Zhang Z., Kolls J.K., Oliver P., Good D., Schwarzenberger P.O., Joshi M.S., Ponthier J.L., Lancaster J.R. Jr. Activation of tumor necrosis factor-alpha-converting enzyme-mediated ectodomain shedding by nitric oxide. J. Biol. Chem. 275:2000;15839-15844.
287. Zhang Z., Oliver P., Lancaster J.R., Schwarzenberger P.O., Joshi M.S., Cork J., Kolls J.K. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 15:2001;303-305.
288. Zheng H., Jiang M., Trumbauer M.E., Sirinathsinghji D.J., Hopkins R., Smith D.W., Heavens R.P., Dawson G.R., Boyce S., Conner M.W. β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell. 81:1995;525-531.
289. Zheng W.H., Bastianetto S., Mennicken F., Ma W., Kar S. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience. 115:2002;201-211.
290. Zhuo M., Holtzman D.M., Li Y., Osaka H., DeMaro J., Jacquin M., Bu G. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J. Neurosci. 15:2000;542-549.